# OnCo record gim-531 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/gim-531/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "gim-531" ;
  schema:name "GIM-531"@en ;
  schema:description "GIM-531 is an experimental oral small molecule from Georgiamune, in phase 1 trials for advanced solid tumours and stage IV melanoma."@en ;
  schema:url <https://onco.cc/drugs/gim-531/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.georgiamune.com/pipeline>, <https://www.georgiamune.com/news>, <https://clinicaltrials.gov/study/NCT06425926>, <https://clinicaltrials.gov/search?intr=GIM-531> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Oral small molecule" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/advanced-melanoma/> ;
  onco:companies <https://onco.cc/companies/georgiamune/> ;
  onco:trials <https://onco.cc/trials/nct06425926/> .